Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
09/2008
09/03/2008CN101254207A Iron supplementary liposome iron and method of preparing the same
09/03/2008CN101254202A Gargle preparations containing diastatin nystatin
09/03/2008CN101254201A Diastatin nystatin menthol combination with cooperating knife-bar
09/03/2008CN101254196A Composite preparations containing double phosphinic acid compounds and vitamin D clathrate and method of preparing the same
09/03/2008CN101254184A Salviol acid B phosphatide complexes and method of preparing the same
09/03/2008CN101254179A Gatifloxacin capsules and method of preparing the same
09/03/2008CN101254178A Gliclazide controlled release tablets
09/03/2008CN101254174A Freeze-dried injection containing carbazochrome sodium sulfonate and method of preparing the same
09/03/2008CN101254173A Soluble semen iris lacteae powder preparations and method of preparing the same
09/03/2008CN101254172A Guacetisal dry-mixing suspending agents and method of preparing the same
09/03/2008CN101254170A An anticancer sustained release injection carrying clorfarabine and its synergist
09/03/2008CN101254169A Sustained-release agent containing tuberculosis-resistance medicament
09/03/2008CN101254167A Tree plant oil women's medical sanitary tampon and method of preparing the same
09/03/2008CN101254166A An anticancer sustained release injection carrying clorfarabine and its synergist
09/03/2008CN101254165A Skin osmosis promoting absorbing agent of cryptotanshinone
09/03/2008CN101254155A Skin preparations for external use
09/03/2008CN101253931A Composite anti-caking agent and method of preparing the same
09/03/2008CN100415894C Process for producing isomaltose and use thereof
09/03/2008CN100415801C Polyethylene glycol amino acid N-internal ring carbonyl anhydride active derivatives, and medicinal bonding compound and gel thereof
09/03/2008CN100415769C Oligomeric or polymerized methylene protein separation and purification process
09/03/2008CN100415297C Preparation method of zinc supplements based on cation exchange resin
09/03/2008CN100415296C Compositions containing inclusion complexes
09/03/2008CN100415295C Method for preparing capsaicin carrier
09/03/2008CN100415247C Strontium compound for treatment of sub-dermal soft tissue pain
09/03/2008CN100415246C Compositions for preparing external carbon dioxide agents
09/03/2008CN100415243C Composition of water soluble Azithromycin salt
09/03/2008CN100415237C Aciclovir compositions containing dimethicone
09/03/2008CN100415234C Antifungal composition with enhanced bioavailability
09/03/2008CN100415223C Controlled releasing oral medicine composition
09/03/2008CN100415220C Method of stabilizing reduced coenzyme Q10
09/03/2008CN100415216C Timed dual release dosage forms comprising short acting hypnotic or salt thereof
09/03/2008CN100415213C Preparation method of medicinal single layer core osmotic pump tablet
09/03/2008CN100415212C An oral preparation containing caderofloxacin lactate
09/03/2008CN100415210C Peptide/lipid complex formation by co-lyophilization
09/03/2008CN100415188C Condom with erectogenic composition
09/03/2008CN100415107C Indian herbal soft drink
09/02/2008US7420085 Form II; used for facilitating the delivery of active agents, such as insulin, to a target
09/02/2008US7420069 Crystalline composition containing escitalopram
09/02/2008US7420042 Soluble neuropilin/growth factor receptor fusion proteins
09/02/2008US7420037 Heat shock protein-based vaccines and immunotherapies
09/02/2008US7420031 comprises protein transduction domains; nuclear localization sequences; fusion proteins; for reversible immortalization of cells
09/02/2008US7420030 Mimetic amino acid sequences for use in prevention and treatment of cell proliferative disorders
09/02/2008US7420029 A tissue-specific transporter function inhibitor has both a ligand structure recognized by a tissue-specific transporter and a polymeric molecular structure incapable of passing through a membrane tissue
09/02/2008US7420002 Amino acid conjugates providing for sustained systemic concentrations of GABA analogues
09/02/2008US7419811 Mutant kinase; anticancer agents; supplying to leukemia blastocytes; antibody which detects cell surface antigen; antiproliferative agent
09/02/2008US7419794 Antibodies specific for CYP1B1
09/02/2008US7419792 Detecting binding of said antigen in tissue sample; treating cells to aid in differentiation, treatment and diagnostic imaging
09/02/2008US7419780 invention relates to the evolution of enzymes in vivo, and drug screening in vivo through the use of chemical inducers of protein dimerization
09/02/2008US7419687 carriers for group IB compounds such as silver nitrate comprising beads made of inert polymers, ceramics or stainless steels, used for treatment of menorrhagia
09/02/2008US7419685 Process for producing solid dosage forms
09/02/2008US7419600 purifying polymer by ion exchange chromatography to obtain a purified polymer
09/02/2008US7419504 Poly(ester amide) block copolymers
09/02/2008CA2461757C Nicotine formulations comprising chocolate and use thereof
09/02/2008CA2461517C Nicotine formulations comprising cocoa and use thereof
09/02/2008CA2440468C Pregabalin lactose conjugates
09/02/2008CA2426956C Pharmaceutical compositions comprising ascomycin derivatives
09/02/2008CA2384922C Topical glycopyrrolate product for the reduction of sweating
09/02/2008CA2372053C Compositions and methods for cancer treatment by selectively inhibiting vegf
09/02/2008CA2351068C Drug delivery device, especially for the delivery of progestins and estrogens
09/02/2008CA2325818C Topical immunostimulation to induce langerhans cell migration
09/02/2008CA2316052C Sustained release formulations of water soluble peptides
09/02/2008CA2306350C Conjugates of galactose-binding lectins and clostridial neurotoxins as analgesics
09/02/2008CA2276269C N-acyl phosphatidylethanolamine-mediated liposomal drug delivery
09/02/2008CA2131662C Improved prodrugs for enzyme mediated activation
08/2008
08/28/2008WO2008103847A2 Bridged polycyclic compound based compositions for the inhibition and amelioration of disease
08/28/2008WO2008103264A2 Polymer particles
08/28/2008WO2008103148A1 An orally-absorbed formulation for paromomycin
08/28/2008WO2008103046A1 A controlled release composition
08/28/2008WO2008103045A1 A controlled release composition comprising a recombinant gelatin
08/28/2008WO2008103044A1 Non-natural recombinant gelatins with enhanced functionality
08/28/2008WO2008102880A1 Antimycotic patch
08/28/2008WO2008102855A1 Composition for treatment of cartilage disease
08/28/2008WO2008102849A1 Hgf preparation
08/28/2008WO2008102452A1 Hgf preparation
08/28/2008WO2008102368A1 Medicinal formulation containing a combination of hiv type i and hiv type ii
08/28/2008WO2008102349A2 Terbinafine formulation for iontophoresis
08/28/2008WO2008102150A2 Composition for combating epistaxis
08/28/2008WO2008102144A2 Aqueous formulations
08/28/2008WO2008102129A1 Delta 9 - tetrahydrocannabinol processing
08/28/2008WO2008101700A2 Bispecific fusion protein having therapeutic and diagnostic potential
08/28/2008WO2008101344A1 Soluble bioactive lipophilic compounds compositions
08/28/2008WO2008080542A3 Combination product for controlling parasites on animals
08/28/2008WO2008080218A9 Methods of selecting and producing modified toxins, conjugates containing modified toxins and uses thereof
08/28/2008WO2008072985A3 Pour on formulation
08/28/2008WO2008060515A3 Topical compositions comprising polyhydroxy acids and/or lactones for improved cutaneous effects of oxidative therapeutic drugs
08/28/2008WO2008051565A3 A drug-release composition having a therapeutic carrier
08/28/2008WO2007113223A3 Immunogenic composition
08/28/2008US20080208167 Methods and compositions to treat myocardial conditions
08/28/2008US20080207883 Platelet Derived Growth Factor (PDGF) Nucleic Acid Ligand Complexes
08/28/2008US20080207877 Granulocyte cell stimulating factor (G-CSF), erythropoietin, interferon, and growth hormone
08/28/2008US20080207778 Support Comprising a Wax Derivative for Making Topical Cosmetic Formulations
08/28/2008US20080207777 Emulsifier System, Emulsion and the Use Thereof
08/28/2008US20080207776 Lipid aggregate for delivery of macromolecules into cells
08/28/2008US20080207775 Method For Producing an Aqueous Suspension and a Powdered Preparation of One or More Carotinoids
08/28/2008US20080207774 Incorporating antimicrobial ingredients into latex during emulsion polymerization instead of after; allows use of higher concentrations of a wide range of bioactive ingredients, including highly hydrophobic ones; homogenous distribution; personal care, textiles, plastics; deodorants, disinfectants
08/28/2008US20080207773 Cosmetic, pharmaceutical and dermatological products
08/28/2008US20080207746 Administering an ultrasonic contrast agent; imaging tissue; medical diagnosis; using halogenated xanthene compound
08/28/2008US20080207668 Pharmaceutical compositions of hydromorphone for prevention of overdose or abuse
08/28/2008US20080207624 Therapeutic Agent for Bh4-Responsive Hyperphenylalaninemia
08/28/2008US20080207623 Peptide-enhanced corneal drug delivery
1 ... 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 ... 1712